Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

IBM Partners With Tekes, Expands Watson Health To Finland

Published 09/14/2016, 10:59 PM
Updated 07/09/2023, 06:31 AM

International Business Machines Corp (NYSE:IBM) recently announced a partnership with Tekes, a Finland-based funding agency. The partnership will enable Finland to make use of cognitive computing technology offered by Watson Health.

Watson Health will help doctors to provide better treatment in the country as well as boost the business ecosystem and innovation related to healthcare in the country.

Advantage Finland

We note that the collaboration will help Finland in many ways. Some of the probable outcomes of the partnership are opening of start-ups, improved opportunities for Finland based companies to grow globally and digitalization of the healthcare sector, which will benefit both small and large companies associated with the field.

Per the deal, Finnish doctors and researchers will collaborate with Watson Health researchers, engineers, data scientists and designers to develop innovative healthcare solutions and applications. This will lead to advancement of research and development and innovation in the country.

IBM is planning to set up a Watson Health Center of Excellence in the country along with a Nordic Healthcare Competence Center and a National Imaging Center of Excellence, both of which will be the first of their kind outside the U.S. IBM intends to employ 150 people in these healthcare centers in the near future.

Finland’s University of Jyvaskyla has been collaborating with IBM Watson for sometime now and the results have been encouraging. Moreover, the focus on digitalization as well as digital services is helping the university to innovate using IBM’s technology.

Our Take

With cognitive computing gradually gaining traction in the healthcare segment with its capability to diagnose diseases accurately, IBM’s Watson Health has huge growth opportunity in healthcare applications. We believe IBM will continue to pursue similar kind of collaborations that will help in expanding its global presence in the long haul.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank & Key Picks

At present, IBM carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader technology space are Lantronix, Inc. (NASDAQ:LTRX) sporting a Zacks Rank #1 (Strong Buy) and NCR Corporation (NYSE:NCR) and VASCO Data Security International Inc. (NASDAQ:VDSI) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Interested in IPOs? Check out the special edition of Zacks Friday Finish Line below, where Editor Maddy Johnson and Content Writer Ryan McQueeney interview Kathleen Smith of Renaissance Capital about the IPO market in 2016 (see part two here).

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



LANTRONIX INC (LTRX): Free Stock Analysis Report

INTL BUS MACH (IBM): Free Stock Analysis Report

NCR CORP-NEW (NCR): Free Stock Analysis Report

VASCO DATA SEC (VDSI): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.